Cite
HARVARD Citation
Engstrøm, T. et al. (2015). Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet. 386 (9994), pp. 665-671. [Online].